Author

Sonia Mazara

OpenAlex ID: A5090725356

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

2020 · Vianney Tricou, Xavier Sáez-Llorens, et al. · The Lancet · 109

Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study

2017 · Xavier Sáez-Llorens, Vianney Tricou, et al. · The Lancet Infectious Diseases · 82

Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic

2023 · Luis Rivera Mejía, Lourdes Peña Méndez, et al. · The Lancet Infectious Diseases · 11

Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults

2012 · Luis Rivera, Sonia Mazara, et al. · Vaccine · 4

Live-attenuated chikungunya vaccine in children: a randomized phase 2 trial

2026 · Petronela Weisová, Susanne Scheiblauer, et al. · Nature Medicine · 2

Phase 2b bivalent GI.1/GII.4c norovirus vaccination in infants and serologic evidence that pre-existing immunity is required for broad GII.4 neutralization

2026 · Lisa Lindesmith, Rodrigo DeAntonio, et al. · Research Square

Works count: 6

Citation count: 208

H-index: 4

I10-index: 3